Translational Development Acquisition Corp. 10-Q

Item 5. Other Information. (a) None. (b) None. (c) During the quarter ended June 30, 2025, none of our directors or officers adopted or terminated a “ Rule 10b5-1 trading agreement” or a “ non-Rule 10b5-1 trading agreement” (in each case defined in Item 408 of Regulation S-K). ​ 23 Table of Contents Item 6. Exhibits. See the Exhibit Index to this Quarterly Report immediately below and before the signature page hereto, which Exhibit Index is incorporated by reference as if fully set forth herein. No. Description of Exhibit 3 ​ Amended and Restated Memorandum and Articles of Association of the Company (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on December 27, 2024) 31.1 Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2 Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1* Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 32.2* Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Labels Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 ​ Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) * Furnished herewith. ​ 24 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ​ ​ ​ ​ Translational Development Acquisition Corp. Date: August 14, 2025 ​ ​ ​ By: /s/ Michael B. Hoffman ​ Name: Michael B. Hoffman ​ Title: Chief Executive Officer ​ ​ (Principal Executive Officer) ​ ​ ​ Date: August 14, 2025 By: /s/ Avanindra C. Das ​ Name: Avanindra C. Das ​ Title: Chief Financial Officer ​ ​ (Principal Financial and Accounting Officer) ​ ​ 25